Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin after hospitalization with pneumonia to prevent heart attacks and stroke
ISRCTN85630652Phase 4Recruiting
- Sponsor
- North Bristol NHS Trust
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of aspirin in pneumonia (2 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Hierarchical composite of cardiovascular and mortality outcomes. Started Nov 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
pneumonia
Beyond the preview
Go deeper on ISRCTN85630652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85630652.